CN
Tel:+86-755-36307888
Fax:+86-755-36307273
Service Email:info@genomics.cn
Media contact:media@genomics.cn
Address:Building 11, Beishan Industrial Zone, Yantian District, Shenzhen(518083)

      

    News Center

News Center

Updates on BGI’s developments in research, education and industry.

首页 About News Center BGI News Community Impact BGI Group Signs MOUs in Indonesia to Support Genomics Development

BGI Group Signs MOUs in Indonesia to Support Genomics Development

November 18, 2022 Views:

BGI Group signed three Memorandum of Understandings (MOUs) in the lead up to the G20 Summit in Bali with the Indonesian Ministry of Health, the University of Indonesia and the Del Institute of Technology (Institut Teknologi Del). The MOUs cover genomics development initiatives, construction of related laboratories, and joint research and personnel training.

Contract Signing.jpgCoordinating Minister of Maritime and Investment Affairs of Indonesia, Luhut Binsar Pandjaitan (third from left), Indonesian Minister of Health, Budi Gunadi Sadikin (second from right), and Chairman and Co-Founder of BGI Group, Wang Jian (second from left) witnessed the signing of the MOU between the Indonesian Ministry of Health and BGI Group

The signings were witnessed by Coordinating Minister of Maritime and Investment Affairs of Indonesia, Luhut Binsar Pandjaitan, Indonesian Minister of Health, Budi Gunadi Sadikin, and Chairman and Co-Founder of BGI Group, Wang Jian.

Meeting.jpgIndonesian Minister of Health, Budi Gunadi Sadikin, holds discussions with Chairman and Co-Founder of BGI Group, Wang Jian

Wang Jian also spoke during the "Tri Hita Karana (THK) Future Knowledge Summit" in Bali, an official side event of the G20 Summit, on “DNA Cell STOmics For All In The Emerging Future”.

WangJian Speech.jpgChairman and Co-Founder of BGI Group, Wang Jian, delivers his speech on “DNA Cell Stomics For All In The Emerging Future”

Genomics was announced as an integral part of the Indonesian Ministry of Health’s medical transformation strategy. On August 14th, 2022, Indonesia established its first national integrated biomedical programme, the “Biomedical and Genome Science Initiative” (BGSi). MGI Tech Co., Ltd. is one of the designated sequencing platform partners for the initiative.